ISPOR 2023 News Center

Explore the news and reporting from ISPOR 2023 in the News Center with curated stories on cutting-edge topics from the conference. Stories are added to the News Center as they are published, so check back often for conference news as it is published.

ISPOR 2023: Impacting Innovation, Value, and Healthcare Decision Making

The ISPOR 2023 annual, international conference—Impacting Innovation, Value, and Healthcare Decision Making—Is a must-attend event that convenes global thought leaders to  discuss how we establish, incentivize, and share value sustainable for health systems, patients, and technology developers. 

How Do You Determine If RWE Is A Good Fit For Your Org? Ask (And Answer) The Right Questions [Clinical Leader]

The US Inflation Reduction Act: what do the experts think? [Office of Health Economics]

Daily Round-Ups: ISPOR 2023 - Wednesday, May 10 [The Evidence Base]

Inside the Final ISPOR 2023 Plenary: Electronic health records [The Evidence Base]

Daily Round-Ups: ISPOR 2023 - Tuesday, May 9 [The Evidence Base]

Inside the Second ISPOR 2023 Plenary: Large language models, artificial intelligence, and the role of the HEOR community in these new areas of innovation [The Evidence Base]

Daily Round-Ups: ISPOR 2023 - Monday, May 8 [The Evidence Base]

Inside the First ISPOR 2023 Plenary: Affordability, value, and the role of the HEOR community [The Evidence Base]

ISPOR 2023: Editor’s picks of the sessions to attend [The Evidence Base]

ISPOR 2023: Preview of the plenary sessions [The Evidence Base]

ISPOR Real-World Evidence Summit 2023: What to expect [The Evidence Base]

Join Global Healthcare Leaders as They Convene at ISPOR 2023 [ISPOR]

Gold Sponsor, Axtria Presents a Thought-Provoking Workshop on “Does Geography Affect Your Health?” and Six Additional HEOR/RWE Studies at ISPOR 2023 [Yahoo! Finance]

Photo Gallery

Additional News From the Conference

Diabetes App Linked With Reduction in All-Cause HCRU, Inpatient Hospitalization Rates [AJMC]

How to Quantify the Economic Impact of Digital Health Solutions [EBN]

Fujitsu Conducts Project with Takeda and National Cancer Center Japan to Analyze and Visualize of Patient Journey with Ovarian Cancer [Kuala Lumpur Week]

Racial Disparities Linked With High Rates of ADT-Related AEs in Prostate Cancer [Targeted Oncology]

Postpartum Depression Increased During the Pandemic, and Many Women Received No Treatment [Evernorth]

Digital Diabetes System Shown to Cut Health Care Use [Science and Enterprise]

Oncologists Report Lasting Changes to Practice Due to COVID-19 [Targeted Oncology]

Real-World Data Shows Significant Increase of Biomarker Testing in Past Decade for NSCLC [Targeted Oncology]

Madrigal Pharmaceuticals Provides Corporate Updates, Reports First Quarter 2023 Financial Results: NASH Epidemiology and Health Economics Outcomes Research Presentations at ISPOR [MyChesCo]

Authentic-Earth Information Exhibit Important Enhance in NSCLC Biomarker Testing More Than the Earlier 10 Years [Archynetys]

Sanofi research demonstrates 9.3% reduction in all-cause healthcare resource utilization rates, including 23.5% decrease in hospitalization for Dario users [WWLP]

Nivolumab Combinations Improve Survival But Are Not Cost-Prohibitive in Advanced ESCC [Targeted Oncology]

Selpercatinib Shows Minimal Payer Budget Impact for RET-Altered Solid Tumors [Targeted Oncology]

New Assessment Scale to Capture Patient Relevant Bleeding to be Presented at ISPOR 2023 [Global News Wire]

Medexus Pharmaceuticals talks cost savings with Gleolan [StockWatch]

DarioHealth Corp. (NASDAQ: DRIO) Reports on Research Presented at Leading Global Conference for Health Economics [Investor Brand Network]

uMotif and Veramed Partner to Offer Advanced Biostatistical Data Analysis, Visualization Combined with Industry-Leading Patient eCOA/ePRO Data Capture and Analytics [PR Business Wire]

Next-Generation eCOA/ePRO Provider uMotif Welcomes SAFIRA Clinical Research Co-founder and Clinical Trial Technology Innovator Willie Muehlhausen as Scientific Advisor [Orange Leader]

Aetion® Launches New Application for Descriptive Analytics and Fast, Reliable Insights [PadovaNews]

Komodo Health Platform Powers 17 Cutting-Edge Health Economics and Outcomes Research Presentations at ISPOR 2023 [Business Wire]

Cognito Therapeutics Announces Poster Presentations at ISPOR 2023 [Business Wire]

Zambon Announces New Data Highlighting Lifetime Burden of Illness in U.S. Patients with Bronchiolitis Obliterans Syndrome at ISPOR 2023 [Cison]

New Assessment Scale To Capture Patient Relevant Bleeding [LifeCare News]

Lurbinectedin Is Cost-Effective as a Second-Line Treatment in SCLC [Targeted Oncology]

Study Reveals Key Factors Guiding Shared Decision-Making for BRAF V600E/K+ Melanoma [Targeted Oncology]

Research to Be Presented at ISPOR 2023 Illuminates the Economic Costs of Melanoma and Non-Small Cell Lung Cancer and Provides Insights That Can Help Strengthen the Quality and Approach to Real-World Evidence Generation [Financial Content]

RxData and Edra Publishing Will Unveil a New Book at ISPOR 2023 [Dentistry33]

Lurbinectedin Is Cost-Effective as a Second-Line Treatment in SCLC [Targeted Oncology]

Flatiron Health Research Highlights Power of Real-World Oncology Data at ISPOR 2023 [Yahoo! Finance]

Inspire Launches Patient-Centered Real-World Evidence, Including Innovative Data And Analytic Solutions [MENAFN]

PicnicHealth Announces the Presentation of Three Abstracts at ISPOR Annual Meeting Highlighting the Utility of Real-World Evidence in Understanding Health Care Utilization in Neurology [Financial Content]

HEOR News Desk

HEOR News Desk

ISPOR News Webpage

ISPOR News

Thank You to ISPOR 2023 Media Partners:

A special thank you to ISPOR 2023's Media Partners—The Evidence Base and the Journal of Medical Economics—and to all the media outlets who are reporting on the conference.

Disclaimer:

The reporting on ISPOR 2023 from external news sources reflects the views of the authors/media outlets and is not endorsed by ISPOR.